v3.26.1
Stockholders’ Equity (Details) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 09, 2026
Jan. 01, 2026
Nov. 05, 2025
Apr. 06, 2022
Mar. 31, 2026
Mar. 31, 2025
Jun. 30, 2026
Mar. 31, 2025
Dec. 31, 2025
May 31, 2021
Dec. 31, 2014
Stockholders’ Equity [Line Items]                        
Warrant to purchase shares of common stock   4,210,527                    
Shares issued   29,474,569                    
Common stock, price per share (in Dollars per share) $ 0.001 $ 0.001           $ 0.001   $ 0.001    
Private investment description   The shares of common stock were sold at an offering price of $4.75 per share, and the pre-funded warrants were sold at an offering price of $4.749 per pre-funded warrant, which represents the per share purchase price for the common stock less the $0.001 per share exercise price for each such pre-funded warrant.                    
Unrecognized stock-based compensation expense (in Dollars) $ 5,800,000             $ 5,800,000        
Weighted average remaining service period               2 years 7 months 13 days        
Aggregate fair value of options (in Dollars)               $ 25,000        
Intrinsic value of warrants exercisable (in Dollars) $ 6.06             $ 6.06        
Number of warrants granted               4,210,527        
Option [Member]                        
Stockholders’ Equity [Line Items]                        
Common stock exercise shares               97,123        
Common stock grants 18,052,942             18,052,942        
Term of stock options               10 years        
Vested term               4 years        
Aggregate fair value of options (in Dollars)                   $ 1.38    
Pre-Funded Warrant [Member]                        
Stockholders’ Equity [Line Items]                        
Restricted common stock               1,682,500        
Common stock exercise value               $ 1,683        
Cashless exercise of warrants               1,682,500        
Warrant to purchase shares of common stock   4,210,527   5,315,000                
Warrant exercise price (in Dollars per share) $ 0.001     $ 0.001       $ 0.001        
Issuance of warrant (in Dollars)   $ 150,000,000   $ 94,000,000                
Number of warrants granted               4,210,527        
Warrant [Member]                        
Stockholders’ Equity [Line Items]                        
Unrecognized stock-based compensation expense (in Dollars) $ 0             $ 0        
Intrinsic value of warrants exercisable (in Dollars) $ 39,914,036             $ 39,914,036        
2014 Stock Option and Equity Incentive Plan [Member] | Board of Directors [Member]                        
Stockholders’ Equity [Line Items]                        
Common stock grants                       5,152,942
2021 Equity Incentive Plan [Member]                        
Stockholders’ Equity [Line Items]                        
Common stock grants                     12,900,000  
2021 Equity Incentive Plan [Member] | Board of Directors [Member]                        
Stockholders’ Equity [Line Items]                        
Common stock grants                     1,500,000  
Common Stock [Member]                        
Stockholders’ Equity [Line Items]                        
Restricted common stock             3,017,420 97,123        
Common stock exercise value     $ 101,497                  
Common stock exercise shares     97,123                  
Shares issued           29,474,569            
Common stock, price per share (in Dollars per share)   $ 0.001                    
Common Stock [Member] | Pre-Funded Warrant [Member]                        
Stockholders’ Equity [Line Items]                        
Warrant to purchase shares of common stock 5,760,527             2,082,500        
Common Stock [Member] | Warrant [Member]                        
Stockholders’ Equity [Line Items]                        
Restricted common stock               2,082,032        
Restricted Common Stock [Member]                        
Stockholders’ Equity [Line Items]                        
Research and development compensation expense (in Dollars)                 $ 905,226      
License Agreement [Member] | Restricted Common Stock [Member]                        
Stockholders’ Equity [Line Items]                        
Restricted common stock                 3,017,420      
Open Market Sale Agreement [Member] | Common Stock [Member]                        
Stockholders’ Equity [Line Items]                        
Aggregate offering price (in Dollars)         $ 100,000,000              
Shares issued